1. Home
  2. YORW vs RIGL Comparison

YORW vs RIGL Comparison

Compare YORW & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YORW
  • RIGL
  • Stock Information
  • Founded
  • YORW 1816
  • RIGL 1996
  • Country
  • YORW United States
  • RIGL United States
  • Employees
  • YORW N/A
  • RIGL N/A
  • Industry
  • YORW Water Supply
  • RIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • YORW Utilities
  • RIGL Health Care
  • Exchange
  • YORW Nasdaq
  • RIGL Nasdaq
  • Market Cap
  • YORW 450.2M
  • RIGL 537.6M
  • IPO Year
  • YORW N/A
  • RIGL 2000
  • Fundamental
  • Price
  • YORW $32.25
  • RIGL $42.20
  • Analyst Decision
  • YORW
  • RIGL Buy
  • Analyst Count
  • YORW 0
  • RIGL 6
  • Target Price
  • YORW N/A
  • RIGL $39.83
  • AVG Volume (30 Days)
  • YORW 99.3K
  • RIGL 652.5K
  • Earning Date
  • YORW 11-06-2025
  • RIGL 11-04-2025
  • Dividend Yield
  • YORW 2.72%
  • RIGL N/A
  • EPS Growth
  • YORW N/A
  • RIGL 2698.26
  • EPS
  • YORW 1.39
  • RIGL 6.20
  • Revenue
  • YORW $76,882,000.00
  • RIGL $282,076,000.00
  • Revenue This Year
  • YORW $7.50
  • RIGL $59.93
  • Revenue Next Year
  • YORW $6.33
  • RIGL N/A
  • P/E Ratio
  • YORW $23.17
  • RIGL $6.77
  • Revenue Growth
  • YORW 3.63
  • RIGL 79.13
  • 52 Week Low
  • YORW $29.68
  • RIGL $14.63
  • 52 Week High
  • YORW $36.60
  • RIGL $43.72
  • Technical
  • Relative Strength Index (RSI)
  • YORW 53.41
  • RIGL 71.32
  • Support Level
  • YORW $31.60
  • RIGL $34.00
  • Resistance Level
  • YORW $32.40
  • RIGL $39.56
  • Average True Range (ATR)
  • YORW 0.85
  • RIGL 2.35
  • MACD
  • YORW -0.03
  • RIGL 1.14
  • Stochastic Oscillator
  • YORW 57.07
  • RIGL 96.84

About YORW York Water Company (The)

The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and eleven wastewater collection and treatment systems. The company operates within its franchised territory, which covers more than 57 municipalities within four counties in south-central Pennsylvania.

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Share on Social Networks: